Guardant Health Surpasses 500 Peer-Reviewed Publications Milestone

PALO ALTO, Calif.–(BUSINESS WIRE)–Guardant Health, Inc. (Nasdaq: GH), a leading precision oncology company, today announced its achievement of surpassing a significant milestone of 500 peer-reviewed publications featuring its technology in esteemed scientific journals. This milestone highlights Guardant Health’s leadership, amassing one of the most robust portfolios of relevant liquid biopsy research studies in the industry. These publications have profoundly impacted the oncology field, incl
Click here to view original post

Click Here to Publish/Feature Your Company or Product News with Biotech Networks